Efficacy of Fenfluramine in Reducing Generalized Tonic-Clonic Seizures: Kelly Knupp, MD
The pediatric epileptologist at Children's Hospital Colorado talked about a comprehensive review of various studies assessing fenfluramine in severe seizures associated with developmental and epileptic encephalopathies. [WATCH TIME: 5 minutes]
WATCH TIME: 5 minutes
"Across the studies, 29% of patients who responded had a 100% response rate for generalized tonic-clonic seizures, which is really quite striking."
Developmental and epileptic encephalopathies (DEEs) are recognized as pharmacoresistant seizures and developmental delay. Patients living with DEEs typically have multiple seizure types, such as tonic–clonic seizures (TCS), which can be generalized tonic–clonic (GTCS) or focal evolving to bilateral tonic–clonic (FBTCS). Prior studies show that fenfluramine (Fintepla; UCB), an FDA-approved antiseizure medication, displayed efficacy in reduction of TCS in patients with Dravet syndrome (DS), Lennox–Gastaut syndrome (LGS), and other DEEs.
A
The median percent reduction in GTCS or TCS from baseline was available in 10 studies (n = 328) and ranged from 47.2% to 100%. In the 4 non-DS publications specifically, the median percent reduction in GTCS or TCS from baseline ranged from 48.8% to 100% in 115 patients. In the three DS randomized controlled trials, median percent reductions in GTCS ranged from 47.2% to 90.8%. In the other DS publications, which consisted of case reports or open-label studies, the median reductions reported were 75.0%, 74.5%, and 100%.
Coauthor
REFERENCES
1. FINTEPLA® (fenfluramine) Results Examining its Impact in Managing Generalized Tonic-Clonic Seizures in Developmental and Epileptic Encephalopathies Published in Epilepsia. News release. June 24, 2024. Accessed July 12, 2024. https://www.ucb-usa.com/stories-media/UCB-U-S-News/detail/article/FINTEPLA-fenfluramine-results-examining-its-impact-in-managing-generalized-tonic-clonic-seizures-in-developmental-and-epileptic-encephalopathies-published-in-epilepsia
2. Nagel AG, Cross HJ, Devinsky O, et al. Comprehensive scoping review of fenfluramine’s role in managing generalize tonic-clonic seizures in developmental and epileptic encephalopathies. Epilepsia. Published online June 21, 2024. doi:10.1111/epi.18020
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.